Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.47 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | STAT1 | P42224 | 1/20 | 0.43 |
| ▸ | TOP1 | P11387 | 4/20 | 0.43 |
| ▸ | CYCS | P99999 | 3/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759942 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL9438544 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL7150430 | 1.00 | TERT (0.47) | TERTSTAT3STAT1TOP1CYCS | |
| Hydrochloric Acid SCHEMBL8182742 | 0.99 | TERT (0.46) | TERTSTAT3STAT1TOP1CYCS | |
| Hydrochloric Acid SCHEMBL8182065 | 0.99 | TERT (0.46) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL18418 | 0.91 | TERT (0.44) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL7246124 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL4138914 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL30474599 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 | |
| SCHEMBL2375486 | 0.90 | TERT (0.43) | TERTTOP1CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5281616-A | Treatment of human immunodeficiency virus infections | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1994-01-25 | — | — | US | claimed |
| US-5192788-A | PORPHYRIN ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1993-03-09 | — | — | US | claimed |
| US-5109016-A | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1992-04-28 | — | — | US | claimed |
| WO-1989011277-A2 | PORPHYRIN AND PHTHALOCYANINE ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1989-11-30 | — | — | WO | claimed |
| CN-114948801-A | Protective composition with relieving effect and preparation method thereof | 深圳减字科技有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-10888569-B1 | Methods and compositions for treating cancer | THE UNIVERSITY OF CHICAGO (US) | 2021-01-12 | — | — | US | disclosed |
| US-20110253197-A1 | TUNED SOLAR CONCENTRATORS AND DEVICES AND METHODS USING THEM | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-10-20 | — | — | US | disclosed |
| US-20100193011-A1 | MATERIALS FOR SOLAR CONCENTRATORS AND DEVICES, METHODS AND SYSTEM USING THEM | ENERGY, UNITED STATES DEPARTMENT OF | 2010-08-05 | — | — | US | disclosed |
| WO-2010085561-A2 | MATERIALS FOR SOLAR CONCENTRATORS AND DEVICES, METHODS AND SYSTEMS USING THEM | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20050192209-A1 | Eosinophil Major Basic Protein as a natural heparanase-inhibiting protein, compositions, methods and uses thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2005-09-01 | — | — | US | disclosed |
| US-20050090428-A1 | Porphyrins with virucidal activity | EMORY UNIVERSITY (US) | 2005-04-28 | — | — | US | disclosed |
| US-6716794-B2 | PHOTOSENSITIZERS OF THE TETRAPYRROL AND/OR TETRAAZOPYRROL FAMILIES HAVING AT LEAST ONE POSITIVE CHARGE AT A SUBSTITUENT FOR CONTROLLING BACTERIAL GERMS AND ALGAE IN AQUARIA | DPC D.O.O. (SI) | 2004-04-06 | — | — | US | disclosed |
| US-6454951-B1 | TETRAPYRROLE AND/OR TETRAAZAPYRROLE COMPOUND, WATER SWELLABLE SOLID CARRIER SELECTED FROM POLYSTYRENE, SEPHADEX AND CLAY, | Jori, Giulio (IT) | 2002-09-24 | — | — | US | disclosed |
| EP-0894011-A2 | DELIVERY OF NUCLEIC ACIDS BY PORPHYRINS | INNOVIR LABORATORIES, INC. (US) | 1999-02-03 | — | — | EP | disclosed |
| WO-1998006440-A2 | PHENOTYPIC CONVERSION OF CELLS MEDIATED BY EXTERNAL GUIDE SEQUENCES | INNOVIR LABORATORIES, INC. (US) | 1998-02-19 | — | — | WO | disclosed |
| WO-1997033622-A2 | DELIVERY OF NUCLEIC ACIDS BY PORPHYRINS | INNOVIR LABORATORIES, INC. (US) | 1997-09-18 | — | — | WO | disclosed |
| US-5281616-A | Treatment of human immunodeficiency virus infections | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1994-01-25 | — | — | US | disclosed |
| US-5192788-A | PORPHYRIN ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1993-03-09 | — | — | US | disclosed |
| US-5109016-A | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1992-04-28 | — | — | US | disclosed |
| WO-1989011277-A2 | PORPHYRIN AND PHTHALOCYANINE ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1989-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090428-A1 | Porphyrins with virucidal activity | ZP1, MAVS, VIP | TERT 869/4885STAT3 3292/4885STAT1 2812/4885 |
| US-10888569-B1 | Methods and compositions for treating cancer | BACH1, BCOR, BCCIP | TERT 190/4885STAT3 728/4885STAT1 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.